Mauricio Lisker‐Melman

4.1k citations
79 papers · 2.8k indexed · 1 hit paper · h-index 23
Topics
Hepatitis C virus research (48 papers)Hepatitis B Virus Studies (45 papers)Liver Disease Diagnosis and Treatment (43 papers)
Journals
New England Journal of MedicineSHILAP Revista de lepidopterologíaAnnals of Internal Medicine

In The Last Decade

Mauricio Lisker‐Melman

76 papers receiving 2.7k citations

Hit Papers

Recombinant Interferon Alfa Therapy for Chronic Hepatitis C198920262001201319892505007501000

Peers

Mauricio Lisker‐Melman
Comparison fields: 5 of 103
  • Hepatology 2.3k
  • Epidemiology 2.0k
  • Rheumatology 378
  • Surgery 278
  • Infectious Diseases 248
Replace Greg Galler with:
Greg Galler United States
Vijayan Balan United States
F. Fabrizi Italy
Rachel Westbrook United Kingdom
Maria Lúcia Gomes Ferraz Brazil
Matthew Cramp United Kingdom
B. Kallinowski Germany
Fabrizio Fabrizi Italy
Russell H. Wiesner United States
Takeshi Sodeyama Japan
Mauricio Lisker‐Melman relative to Greg Galler United States Greg Galler's profile →
Citations per field
00.5×3.3×
Greg Galler · 1×
Citations per year

Countries citing papers authored by Mauricio Lisker‐Melman

Since Specialization
Citations

This map shows the geographic impact of Mauricio Lisker‐Melman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauricio Lisker‐Melman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauricio Lisker‐Melman more than expected).

Fields of papers citing papers by Mauricio Lisker‐Melman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauricio Lisker‐Melman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauricio Lisker‐Melman. The network helps show where Mauricio Lisker‐Melman may publish in the future.

Co-authorship network of co-authors of Mauricio Lisker‐Melman

This figure shows the co-authorship network connecting the top 25 collaborators of Mauricio Lisker‐Melman. A scholar is included among the top collaborators of Mauricio Lisker‐Melman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauricio Lisker‐Melman. Mauricio Lisker‐Melman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 11
3 11
4 3
5 5
6 6
7 12
8 49
9 16
10 5
11 16
12 2
13 12
14 12
15 14
16 14
17 76
18 5
19 26
20
Recombinant Interferon Alfa Therapy for Chronic Hepatitis Cbreakdown →
1054

About Mauricio Lisker‐Melman

Mauricio Lisker‐Melman is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 79 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (48 papers), Hepatitis B Virus Studies (45 papers) and Liver Disease Diagnosis and Treatment (43 papers). The work is most often cited by research in Hepatology (2.3k citations), Epidemiology (2.0k citations) and Transplantation (92 citations). Mauricio Lisker‐Melman has collaborated with scholars based in United States, Canada and Mexico. Frequent co-authors include Jay H. Hoofnagle, Adrian M. Di Bisceglie, Chris Kassianides, Linda Murray, Jeanne G. Waggoner, Zachary Goodman, Steven M. Banks, Paul Martin, Jeffrey S. Crippin and Paul Martin. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026